ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
12.14 EUR
0 (0%)
Taking everything into account, IBAB scores 4 out of 10 in our fundamental rating. IBAB was compared to 62 industry peers in the Health Care Equipment & Supplies industry. While IBAB is still in line with the averages on profitability rating, there are concerns on its financial health. IBAB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
IBAB had positive earnings in the past year.
In the past year IBAB had a positive cash flow from operations.
IBAB had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
IBAB has a Return On Assets (2.71%) which is in line with its industry peers.
IBAB's Return On Equity of 14.29% is fine compared to the rest of the industry. IBAB outperforms 80.00% of its industry peers.
With an excellent Return On Invested Capital value of 15.54%, IBAB belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IBAB is below the industry average of 9.74%.
The last Return On Invested Capital (15.54%) for IBAB is above the 3 year average (6.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
IBAB has a Profit Margin (2.85%) which is in line with its industry peers.
In the last couple of years the Profit Margin of IBAB has declined.
With a Operating Margin value of 6.48%, IBAB perfoms like the industry average, outperforming 44.62% of the companies in the same industry.
IBAB's Operating Margin has improved in the last couple of years.
The Gross Margin of IBAB (31.21%) is worse than 84.62% of its industry peers.
In the last couple of years the Gross Margin of IBAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBAB is creating value.
The number of shares outstanding for IBAB has been increased compared to 1 year ago.
IBAB has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IBAB has a worse debt to assets ratio.
2.2 Solvency
IBAB has an Altman-Z score of 1.65. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
IBAB has a worse Altman-Z score (1.65) than 67.69% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.23, IBAB is doing good in the industry, outperforming 66.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.65 |
ROIC/WACC2.15
WACC7.23%
2.3 Liquidity
IBAB has a Current Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB has a worse Current ratio (0.94) than 86.15% of its industry peers.
IBAB has a Quick Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB has a Quick ratio of 0.62. This is amonst the worse of the industry: IBAB underperforms 86.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 112.86% over the past year.
IBAB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.99% yearly.
Looking at the last year, IBAB shows a quite strong growth in Revenue. The Revenue has grown by 15.96% in the last year.
The Revenue has been growing by 12.01% on average over the past years. This is quite good.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
IBAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.72% yearly.
IBAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.63% yearly.
EPS Next Y141.9%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue Next Year23.68%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.30, IBAB is valued on the expensive side.
76.92% of the companies in the same industry are more expensive than IBAB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.92, IBAB is valued a bit cheaper.
With a Price/Forward Earnings ratio of 11.50, the valuation of IBAB can be described as very reasonable.
Based on the Price/Forward Earnings ratio, IBAB is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.46. IBAB is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.3 | ||
| Fwd PE | 11.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBAB indicates a rather cheap valuation: IBAB is cheaper than 87.69% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.32 |
4.3 Compensation for Growth
IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBAB's earnings are expected to grow with 67.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)5.34
EPS Next 2Y109.12%
EPS Next 3Y67.72%
5. Dividend
5.1 Amount
IBAB has a Yearly Dividend Yield of 1.38%.
Compared to an average industry Dividend Yield of 1.11, IBAB pays a bit more dividend than its industry peers.
IBAB's Dividend Yield is slightly below the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.38% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
8.05% of the earnings are spent on dividend by IBAB. This is a low number and sustainable payout ratio.
DP8.05%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EBR:IBAB (12/24/2025, 7:00:00 PM)
12.14
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap367.60M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.62 (20.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.38% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.27%
PT rev (3m)-2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.91%
EPS NY rev (3m)-10.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.04%
Revenue NY rev (3m)1.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.3 | ||
| Fwd PE | 11.5 | ||
| P/S | 0.62 | ||
| P/FCF | N/A | ||
| P/OCF | 132.04 | ||
| P/B | 3.09 | ||
| P/tB | 3.9 | ||
| EV/EBITDA | 8.32 |
EPS(TTM)0.57
EY4.7%
EPS(NY)1.06
Fwd EY8.7%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.76%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.15
PEG (5Y)5.34
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.65 |
F-Score7
WACC7.23%
ROIC/WACC2.15
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y141.9%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year23.68%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year221.54%
EBIT Next 3Y67.42%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 5 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 21.3 and the Price/Book (PB) ratio is 3.09.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 141.9% in the next year.